Tempest Therapeutics Inc (TPST) Stock Analysis

Tempest Therapeutics Inc (TPST) is a publicly traded company in the HEALTHCARE sector. It trades at $1.31, carries a market capitalization of $22.65M. This page summarizes the public market data, fundamentals, and frequently asked questions for TPST, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Tempest Therapeutics Inc currently has a Neutral sentiment score of 0.03.

About Tempest Therapeutics Inc

Tempest Therapeutics Inc. (TPST) is an innovative clinical-stage oncology company based in South San Francisco, California, focusing on the development of proprietary small molecules designed to harness both targeted therapies and immune-mediated mechanisms for the treatment of diverse tumors. With a commitment to advancing cancer therapeutics, Tempest's pipeline includes compounds that aim to improve patient outcomes in challenging oncology indications, positioning the company at the forefro...

GNG Research Analysis

GNG Research scores Tempest Therapeutics Inc (TPST) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TPST.

Frequently Asked Questions

Does TPST pay dividends?

Tempest Therapeutics Inc (TPST) does not currently pay a regular dividend.

What is TPST's market cap?

Tempest Therapeutics Inc (TPST) has a market capitalization of $22.65M with a current stock price of $1.31.